How does the occurrence of a fragility fracture affect osteoporotic treatment decisions?

• A. It is a red flag that accelerates the need for pharmacologic therapy and strong preventive measures regardless of BMD.
• B. It suggests stopping therapy.
• C. It has no impact on treatment decisions.
• D. It means only lifestyle changes are needed.

Answer: (A)

A fragility fracture shows that bone strength is compromised and that future fracture risk is high. This event makes the risk of another fracture much greater, independent of what the current bone density score might be. Because of that elevated risk, starting pharmacologic osteoporosis therapy and applying strong preventive measures is the most appropriate response, even if bone density isn’t severely low. The aim is to reduce fracture risk by stabilizing bone turnover and increasing bone strength, using appropriate medications (such as antiresorptives or anabolic agents when indicated), while also ensuring adequate calcium and vitamin D, addressing reversible risk factors, and reducing fall risk. Lifestyle changes remain important but alone are not enough when a fragility fracture has occurred.

Stopping therapy or treating with lifestyle changes only would miss the opportunity to significantly lower the chance of another fracture, and treating as if there were no impact at all ignores the clear signal that fracture history provides about future risk.